Petra Macaskill

Petra Macaskill

Auto-generated profile, based on publicly available information

Petra Macaskill

University of Sydney

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 July 2011 in BMJ
Verified
Journal Article
Open access
PDF file
JSJonathan A C Sterne
Jonathan A C Sterne
ASAlex J Sutton
Alex J Sutton
JIJ. P. A. Ioannidis
J. P. A. Ioannidis
NTNorma Terrin
Norma Terrin
DJDavid R Jones
David R Jones
JHJulian P T Higgins
Julian P T Higgins
Funnel plots, and tests for funnel plot asymmetry, have been widely used to examine bias in the results of meta-analyses. Funnel plot asymmetry should not be equated with publication bias, because it has a number of other possible causes. This article describes how to interpret funnel plot asymmetry, recommends appropriate tests, and explains the implications for choice of meta-analysis model

6 January 2015 in Annals of Internal Medicine
Verified
Journal Article
Open access
PDF file
KMKarel G.M. Moons
Karel G.M. Moons
DADouglas G. Altman
Douglas G. Altman
JRJohannes B. Reitsma
Johannes B. Reitsma
JIJohn P.A. Ioannidis
John P.A. Ioannidis
PMPetra Macaskill
Petra Macaskill
GCGary S. Collins
Gary S. Collins
The TRIPOD (Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis) Statement includes a 22-item checklist, which aims to improve the reporting of studies developing, validating, or updating a prediction model, whether for diagnostic or prognostic purposes. The TRIPOD Statement aims to improve the transparency of the reporting of a prediction model study regardless of the study methods used. This explanation and elaboration document describes the rationale; clarifies the meaning of each item; and discusses why transparent reporting is important, with a view to assessing risk of bias and clinical usefulness of the prediction model. Each checklist item of the TRIPOD Statement is explained in detail and accompanied by published examples of good reporting. The document also provides a valuable reference of issues to consider when designing, conducting, and analyzing prediction model studies. To aid the editorial process and help peer reviewers and, ultimately, readers and systematic reviewers of prediction model studies, it is recommended that authors include a completed checklist in their submission. The TRIPOD checklist can also be downloaded from www.tripod-statement.org.

1 September 2005 in Journal of Clinical Epidemiology
Verified
Journal Article
Closed access
JDJonathan J. Deeks
Jonathan J. Deeks
PMPetra Macaskill
Petra Macaskill
LILes Irwig
Les Irwig

5 February 2001 in Statistics in Medicine
Verified
Journal Article
Closed access
PDF file
PMPetra Macaskill
Petra Macaskill
SWStephen D. Walter
Stephen D. Walter
LILes Irwig
Les Irwig

1 June 2013 in The Lancet Oncology
Verified
Journal Article
Closed access
SCStefano Ciatto
Stefano Ciatto
NHNehmat Houssami
Nehmat Houssami
DBDaniela Bernardi
Daniela Bernardi
FCFrancesca Caumo
Francesca Caumo
MPMarco Pellegrini
Marco Pellegrini
PMPetra Macaskill
Petra Macaskill

1 July 2008 in Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
NHNehmat Houssami
Nehmat Houssami
SCStefano Ciatto
Stefano Ciatto
PMPetra Macaskill
Petra Macaskill
SLSarah J. Lord
Sarah J. Lord
RWRuth M. Warren
Ruth M. Warren
LILes Irwig
Les Irwig
Purpose We review the evidence on magnetic resonance imaging (MRI) in staging the affected breast to determine its accuracy and impact on treatment. Methods Systematic review and meta-analysis of the accuracy of MRI in detection of multifocal (MF) and/or multicentric (MC) cancer not identified on conventional imaging. We estimated summary receiver operating characteristic curves, positive predictive value (PPV), true-positive (TP) to false positive (FP) ratio, and examined their variability according to quality criteria. Pooled estimates of the proportion of women whose surgery was altered were calculated. Results Data from 19 studies showed MRI detects additional disease in 16% of women with breast cancer (N = 2,610). MRI incremental accuracy differed according to the reference standard (RS; P = .016) decreasing from 99% to 86% as the quality of the RS increased. Summary PPV was 66% (95% CI, 52% to 77%) and TP:FP ratio was 1.91 (95% CI, 1.09 to 3.34). Conversion from wide local excision (WLE) to mastectomy was 8.1% (95% CI, 5.9 to 11.3), from WLE to more extensive surgery was 11.3% in MF/MC disease (95% CI, 6.8 to 18.3). Due to MRI-detected lesions (in women who did not have additional malignancy on histology) conversion from WLE to mastectomy was 1.1% (95% CI, 0.3 to 3.6) and from WLE to more extensive surgery was 5.5% (95% CI, 3.1 to 9.5). Conclusion MRI staging causes more extensive breast surgery in an important proportion of women by identifying additional cancer, however there is a need to reduce FP MRI detection. Randomized trials are needed to determine the clinical value of detecting additional disease which changes surgical treatment in women with apparently localized breast cancer.